Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Emerging Infectious Diseases|July 19, 2005
Yersinia pseudotuberculosis septicemia and HIVMaria Grazia Paglia, Silvia D'Arezzo, Anna Festa, et al.Microorganisms|August 28, 2025
A Single-Center Retrospective Study on Early Treatment for COVID-19 in Solid Organ Transplant Recipients During the Omicron Era: Outcomes and SARS-CoV-2 Viral KineticsEugenia Milozzi, Elisa Biliotti, Alessandro Caioli, et al.Journal of Medical Virology|April 4, 2018
Significance of detectable HCV RNA below the limit of quantification in patients treated with DAAs using standard and ultrasensitive protocolsUbaldo Visco-Comandini, Daniele Lapa, Raffaella Lionetti, et al.In Vivo (Athens, Greece)|December 24, 2002
Immunohistochemical study of apelin, the natural ligand of receptor APJ, in a case of AIDS-related cachexiaVincenzo Esposito, Maria De Falco, Luca De Luca, et al.Infection and Drug Resistance|November 23, 2018
Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agentsClaudia Minosse, Marina Selleri, Emanuela Giombini, et al.Antibiotics (Basel, Switzerland)|July 27, 2026
Gut Colonisation and Multidrug-Resistant Urinary Tract Infections in Hospitalised Kidney Transplant Recipients: A Single-Centre Retrospective StudyLaura Loiacono, Assunta Navarra, Claudia Rotondo, et al.Journal of the International AIDS Society|November 15, 2014
Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohortCarmela Pinnetti, Simona Di Giambenedetto, Franco Maggiolo, et al.BMC Infectious Diseases|August 13, 2016
Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational studyAlessandra Latini, Massimiliano Fabbiani, Vanni Borghi, et al.Journal of the International AIDS Society|November 15, 2014
Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysisMauro Zaccarelli, Massimiliano Fabbiani, Carmela Pinnetti, et al.Antibiotics (Basel, Switzerland)|May 27, 2026
High-Resolution Genomic Surveillance of Carbapenem-Resistant Acinetobacter baumannii: IC-2 Clonal Diversity, Resistance Determinants, and Virulence SignaturesArianna Basile, Valentina Antonelli, Claudia Rotondo, et al.Pageof 2